Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin vs Hyaluronic Acid for Knee Osteoarthritis
NCT02832713Phase 2Unknown
- Sponsor
- Strasbourg University Hospital
- Start
- Jun 2017
- Primary completion
- Oct 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of botulinum toxin type A in knee osteoarthritis (OA) (2 arms), sponsored by Strasbourg University Hospital. Primary endpoint: Western Ontario and McMaster Universities Osteoarthritis Index pain sub-score at 3 months. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02832713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02832713.